Featured
Deep Learning Applications in Glaucoma Diagnosis and Management
A technology poised to enable earlier detection and diagnosis.
By Ehsan Rahimy, MD
The iStent Inject MIGS Device
Data on this new, smaller stent show reduction in IOP and medications.
By Thomas W. Samuelson, M.D.
The Durability of MIGS
The long-term picture with new glaucoma implants that are less invasive.
By E. Randy Craven, MD, Mary Qiu, MD
Refractive Surprise in Glaucoma Patients
New data can help surgeons plan ahead.
By Nathan M. Radcliffe, MD, Leonard K. Seibold, MD
Rho Kinase Inhibitors for Glaucoma
A novel class of drugs to lower intraocular pressure.
By Angelo P. Tanna, MD
Update on Risk Factors for Glaucoma Progression
Identify and treat glaucoma at an earlier stage.
By Nathan M. Radcliffe, MD, Daniela Alvarez-Ascencio, MD
Departments
Coding: Concurrent Ophthalmoscopy and Retinal Imaging
By Kevin J. Corcoran, COE, CPC, CPMA, FNAO
Glaucoma Myth Busters: Reduce Pressure in a Range of Patient Populations With SLT
By Nathan M. Radcliffe, MD, Inder Paul Singh, MD
Patients Are Asking: “What Else Can I Do?”
By Arsham Sheybani, MD
Product Spotlight: Setting a New Standard in OCTA Imaging and Assessment
By Karen Appold, contributing writer
Web Exclusives
Contact Lens Changes Color as It Releases Drugs
Researchers develop drug-eluting lens tested using timolol.
By Jerry Helzner, contributing editor
Task Force Sees Implant Depth as CyPass Problem
The MIGS device has been voluntarily withdrawn from the market.
By Jerry Helzner, contributing editor
FDA Approves Glaukos iStent Inject
By Jerry Helzner, contributing editor
Genetic Variants Can Help Predict Glaucoma Risk
By Jerry Helzner, contributing editor
Neuron Protection Seen as Reducing Glaucoma Risk
By Jerry Helzner, contributing editor
MIGS Device Is Promising in Trial
By Jerry Helzner, contributing editor
Retina Drug Studied for Potential IOP Lowering
By Jerry Helzner, contributing editor
GonioPen Offers Easier Gonioscopy
By Jerry Helzner, contributing editor